Langerhans Cell Histiocytosis
What's New
Last Posted: Jun 14, 2024
- BRAF-V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first-line therapy.
Chan-Juan Wang, et al. Pediatric blood & cancer 2024 0 e31099 - Ocular findings in patients with histiocytosis and association with clinical and molecular features.
Jasmine H Francis, et al. The British journal of ophthalmology 2024 0 - Genetic Landscape and Its Prognostic Impact in Children With Langerhans Cell Histiocytosis.
Chan-Juan Wang, et al. Archives of pathology & laboratory medicine 2024 0 - Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasms.
Paul G Kemps, et al. Histopathology 2024 0 - Germline mutations in cancer predisposition genes among pediatric patients with cancer and congenital anomalies.
Gustavo D Dangoni, et al. Pediatric research 2024 0 - The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease.
Jia-Wen Dai, et al. Annals of hematology 2023 0 - Impact of BRAF mutation on aggressiveness and outcomes in adult clonal histiocytosis.
Jerome Razanamahery, et al. Frontiers in immunology 2023 0 1260193 - Vulvar Langerhans cell histiocytosis: Clinicopathologic characteristics, mutational profile, and treatment of 4 patients in a single-center cohort.
Ruben Renier, et al. JAAD case reports 2023 0 78-81 - Tazemetostat for Tumors Harboring SMARCB1/SMARCA4 or EZH2 Alterations: Results from NCI-COG Pediatric MATCH APEC1621C.
Susan N Chi, et al. Journal of the National Cancer Institute 2023 0 - Molecular and clinicopathologic characterization of pediatric histiocytoses.
Zofia Hélias-Rodzewicz, et al. American journal of hematology 2023 0
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: